Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma
Clinical trial NCT00705250 · COMPLETED
Trial details
- NCT number
- NCT00705250
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2015-12-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.